Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Completion of Share Repurchase Program

6 Aug 2024 07:00

RNS Number : 2556Z
Indivior PLC
06 August 2024
 

INDIVIOR PLC (THE 'COMPANY')

Completion of Share Repurchase Program

August 6, 2024

 

Indivior PLC announces that the share repurchase program announced on November 17, 2023 to repurchase its ordinary shares of $0.50 each (the "Shares") for cancellation has now completed.

 

In aggregate, Morgan Stanley & Co. International Plc, who undertook the program on the Company's behalf, purchased 5,944,547 Shares for a total consideration of $99,985,139.07 at an average price of £13.2821 per Share.

 

Following completion of the above program, the Company has now commenced the share repurchase program announced on July 25, 2024 under which it will purchase Shares for up to a maximum consideration of $100m during the period commencing on the business day following the completion of the above program and ending no later than January 31, 2025.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

 

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPAMFTMTJMBFI
Date   Source Headline
7th Jul 20212:09 pmRNSHolding(s) in Company
1st Jul 20218:27 amRNSTotal Voting Rights
1st Jul 20217:00 amRNSIndivior Completes Replacement of Term Loans
30th Jun 20217:00 amRNSIndivior Raises FY 2021 Guidance
11th Jun 202110:40 amRNSHolding(s) in Company
8th Jun 202112:30 pmRNSIndivior Agreement for Asset Targeting Cannabis
25th May 202110:00 amRNSIndivior to Participate in Conference
10th May 20212:00 pmRNSBlock listing Interim Review
6th May 20215:30 pmRNSResult of AGM
29th Apr 202112:00 pmRNS1st Quarter Results
28th Apr 20217:00 amRNSStatement re: State Announcements
12th Apr 202111:00 amRNSNotice of Results
1st Apr 202110:00 amRNSTotal Voting Rights
31st Mar 20212:50 pmRNSAnnual Report and Notice of Annual General Meeting
24th Mar 20217:00 amRNSBoard Appointments & Succession Plan Announced
9th Mar 20212:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
1st Mar 20218:00 amRNSTotal Voting Rights
18th Feb 20217:00 amRNSFinal Results
4th Feb 20211:55 pmRNSNotice of Results
3rd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20218:00 amRNSTotal Voting Rights
29th Jan 20214:58 pmRNSHolding(s) in Company
25th Jan 20215:14 pmRNSIndivior Reaches Settlement with Reckitt Benckiser
25th Jan 20218:00 amRNSHolding(s) in Company
20th Jan 20217:00 amRNSHolding(s) in Company
15th Jan 20213:04 pmRNSHolding(s) in Company
15th Jan 20217:00 amRNSIndivior Provides Preliminary FY 2020 Results
11th Jan 20211:00 pmRNSDirectorate Change
4th Jan 202110:29 amRNSTotal Voting Rights
4th Dec 202012:30 pmRNSDirector/PDMR Shareholding
4th Dec 20209:21 amRNSHolding(s) in Company
2nd Dec 20205:13 pmRNSHolding(s) in Company
30th Nov 20207:00 amRNSFurther statement re claim filed by RB
27th Nov 202011:24 amRNSClaim filed by Reckitt Benckiser Group - Amendment
27th Nov 202010:44 amRNSClaim filed by Reckitt Benckiser Group plc
24th Nov 20209:30 amRNSHolding(s) in Company
20th Nov 202011:30 amRNSAppointment of Chief Financial Officer
19th Nov 20207:00 amRNSAppointment of Non-Executive Chair
13th Nov 20207:00 amRNSCourt Approves Agreement with Justice Department
10th Nov 20207:00 amRNSIndivior to Participate in Upcoming Conferences
9th Nov 20208:48 amRNSBlock listing Interim Review
6th Nov 20202:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20204:45 pmRNSHolding(s) in Company
29th Oct 202011:00 amRNS3rd Quarter Results
23rd Oct 20207:00 amRNSStatement re US Court Sentencing of Former CEO
15th Oct 20207:00 amRNSNotice of Results
6th Oct 20209:10 amRNSHolding(s) in Company
5th Oct 20202:41 pmRNSHolding(s) in Company
1st Oct 20209:11 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.